Midostaurin

Midostaurin is a targeted cancer medication used to treat certain blood cancers, such as acute myeloid leukemia with specific genetic mutations. It works by blocking multiple enzymes called kinases, which are involved in cancer cell growth and survival. By inhibiting these kinases, midostaurin helps prevent the cancer cells from multiplying and spreading. It is typically used alongside standard chemotherapy to improve treatment outcomes. While it can be effective, it may also cause side effects, so its use is carefully managed by healthcare providers.